New perspectives in bronchial asthma: pathological, immunological alterations, biological targets, and pharmacotherapy.

Abstract excerpt

Asthma is the most common, long-lasting inflammatory airway disease that affects more than 10% of the world population. It is characterized by bronchial narrowing, airway hyperresponsiveness, vasodilatation, airway edema, and stimulation of sensory nerve endings that lead to recurring events of breathlessness, wheezing, chest tightness, and coughing. It is the main reason for global morbidity and occurs as a...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Anti-Asthmatic Agents
• Share to Anti-Inflammatory Agents